ARIMIDEX is an aromatase inhibitor with over 10 years of clinical data—5 years on treatment and more than 5 years of follow-up—in the initial adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women.
Learn about ARIMIDEX
If you have recently been diagnosed with early breast cancer or are new to hormonal breast cancer treatment, it's time to learn how ARIMIDEX 1 mg may help reduce your risk of breast cancer recurrence.
What is ARIMIDEX?
ARIMIDEX is a prescription medicine approved as an adjuvant treatment for postmenopausal women with hormone receptor-positive early breast cancer. ARIMIDEX is also approved for the initial treatment of postmenopausal women with hormone-receptor positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. ARIMIDEX 1 mg is a hormonal treatment that helps fight breast cancer by lowering the amount of the hormone estrogen in the body.